MBX Biosciences files intention to go public
The five-year-old, clinical-stage drugmaker has already raised more than $213 million to develop therapeutics to treat rare endocrine disorders, a huge amount for a startup.
Health Care & Insurance
Articles
FDA approves updated COVID-19 vaccines; shots should be available in days
With the Food and Drug Administration’s clearance, Pfizer and Moderna are set to begin shipping millions of doses.
Medicaid advisory panel weighs in on HIP lawsuit, PathWays transition
Legislators on the state’s Medicaid Advisory Committee spent hours Wednesday questioning state officials about Indiana’s ongoing lawsuit over provisions of the Healthy Indiana Plan.
Study: Lilly’s Zepbound cut risk of diabetes by 94% in obese people
The longest continuous study of Indianapolis-based Lilly’s drug Zepbound to date included more than 1,000 patients.
Lilly opens new 12-story, $700M R&D center in Boston
Lilly is moving about 200 scientists and researchers who had worked in nearby Cambridge, Massachusetts, to the new center, and plans to add about 300 employees.
IU med school grad gifts $5M to support new anatomy lab
The lab, which will be located on the second floor of the 11-story IU Medical Education and Research Building, will emphasize hands-on physical dissection as a vital component of medical training.
Purdue, Lilly establish medical-focused research center
The Eli Lilly and Co. and Purdue University Research Alliance Center involves more than 50 researchers and 65 graduate students.
Eli Lilly taps blue-chip bond market to fund Morphic acquisition
Lilly is buying Morphic for $3.2 billion to gain experimental therapies for inflammatory bowel disease and other chronic illnesses.
Rokita dismisses IU Health privacy case
Indiana Attorney General Todd Rokita’s office in its own dismissal filing said the case was no longer necessary because discovery in the case has shown IU Health has taken actions to satisfy deficiencies in its policies.
Indiana, 14 other states sue to block Biden effort to help migrants get health coverage
The states hope to block a rule that is expected to allow 100,000 immigrants brought to the U.S. illegally as children to enroll next year in the federal Affordable Care Act’s health insurance.
Novo Nordisk’s Wegovy sales hit by competition from Eli Lilly
Novo is vying with Indianapolis-based Lilly for supremacy in the pharmaceutical industry’s fastest-growing new business, obesity drugs. The market is expected to reach $130 billion by the end of the decade.
Highly anticipated Indiana All Payer Claims Database launched
The Indiana All Payer Claims Database website is expected to provide transparency to health care costs and allow consumers to compare prices across multiple health systems.
Fast-growing MBX Biosciences raises another $63.5 million in funding
MBX is focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, such as hypoparathyroidism, post-bariatric hypoglycemia and obesity.
Tech startup Arrive recruits former Carmel mayor, Elevance CFO
The two additions could help Arrive AI—a maker of smart mailboxes with security and temperature-control features—to gain more traction with municipalities and health care providers.
Charitable care from Hoosier not-for-profit hospitals remains stagnant while revenue increases
Meanwhile, health care systems continue to send thousands of Hoosiers to court over unpaid sums as small as $250.
IU Health operating income falls 73% in first six months of 2024
Indiana University Health, one of the state’s largest hospital systems, saw patient volumes and revenue grow in the first six months of the year, but saw operating income fall as the costs of labor, supplies and drugs increased to meet higher demand for surgeries and patient care.
Boar’s Head expands recall to include 7M more pounds of deli meats
The recalls are tied to an ongoing outbreak of listeria poisoning that has killed two people and sickened nearly three dozen in 13 states, according to the U.S. Centers for Disease Control and Prevention.
Groups launch hospital-linked violence intervention program
The program aims to reduce the likelihood of future violence by engaging victims of gun violence and their families with long-term services and support.
Plaintiffs push back against state’s legal response in HIP lawsuit
Plaintiffs rejected a state motion to reinstate its authority to impose premium-like charges on Medicaid beneficiaries under the Healthy Indiana Plan, urging the court to reject the state’s arguments.
Novo’s diabetes drug shows mixed results in Alzheimer’s trial
Victoza yielded mixed results in a mid-stage study of Alzheimer’s disease, failing to meet its primary goal while showing hints that larger trials of similar drugs may be successful.